OpenVSafe by OpenVAERS
Search V-safe

2NV-34748-58368

3 vaccinations 12 coded responses 33 check-ins 12 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
432 / OH
Registered
2021-03-27
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-03-26
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-27
    Registered in v-safe
  3. 2021-03-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  4. 2021-03-28
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site bruising — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Very bad bruise at the injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-29
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site bruising — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Larger bruise at injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-30
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site bruising — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Bruise at injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  8. 2021-04-01
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pre-existing disease — Feeling: Fair · Site: Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Raynaud's Flare (intermittent, from day two post-shot)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-04-02
    Health check-in — day 7, dose 1
    Feeling: Good · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activities
    Adult check-in
  10. 2021-04-09
    Survey response — day 14, dose 1
    MedDRA: Temperature intolerance — Feeling: Fair
    Free text: Heat intolerance
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-04-16
    Survey response — day 21, dose 1
    MedDRA: Emotional disorder — Feeling: Good
    Free text: Emotional regulation
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-04-22
    Dose 2 — Pfizer-BioNTech
  13. 2021-04-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work
    Adult check-in
  14. 2021-04-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-04-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches
    Adult check-in
  16. 2021-04-27
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cognitive disorder, Sensory overload, Temperature intolerance — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Cognitive issues - problems with sensory overload; heat intolerance
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-28
    Survey response — days 1–6 daily, dose 2
    MedDRA: Temperature intolerance — Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Heat intolerance
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-04-29
    Survey response — day 7, dose 2
    MedDRA: Temperature intolerance — Feeling: Good · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Heat intolerance
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-05-06
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-05-13
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-20
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-27
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-06-03
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-07-22
    Survey response — 3 months, dose 2
    MedDRA: Dysmenorrhoea, Hypersensitivity, Nasopharyngitis, Pre-existing disease, Rash — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: - Terrible menstrual pain foe the last three cycles - A cold that will not go away (3 weeks in the running)- Elevated allergies (skin rash)
    MedDRA releases: 2024-11 · check-in free text available
  25. 2021-07-22
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  26. 2021-07-28
  27. 2021-10-21
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-10-22
    Dose 3 — Pfizer-BioNTech
  29. 2021-10-22
    Health check-in — day 0, dose 3
    Feeling: Good · Headache
    Adult check-in
  30. 2021-10-23
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches
    Adult check-in
  31. 2021-10-25
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Muscle or body aches
    Adult check-in
  32. 2021-10-26
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  33. 2021-10-28
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Headache
    Adult check-in
  34. 2021-10-31
    Health check-in — day 7, dose 3
    Feeling: Fair · Site: Pain · Headache, Joint pains
    Adult check-in
  35. 2021-11-05
    Health check-in — day 14, dose 3
    Feeling: Fair
    Adult check-in
  36. 2021-11-19
    Health check-in — day 28, dose 3
    Feeling: Fair
    Adult check-in
  37. 2021-12-03
    Survey response — day 42, dose 3
    MedDRA: Lethargy — Feeling: Fair
    Free text: Lethargy
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-01-21
    Survey response — 3 months, dose 3
    MedDRA: Food intolerance — Feeling: Good · Be unable to do your normal daily activities
    Free text: Increased food sensitivities
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-04-24
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-26Pfizer-BioNTech
22021-04-22Pfizer-BioNTech
32021-10-22Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 6 — days 1–6 daily, dose 1

2021-03-28

Systemic reaction (other): Very bad bruise at the injection site

2021-03-29

Systemic reaction (other): Larger bruise at injection site

2021-03-30

Systemic reaction (other): Bruise at injection site

2021-04-01

Systemic reaction (other): Raynaud's Flare (intermittent, from day two post-shot)

Release 7 — day 14, dose 1

2021-04-09

Symptoms: Heat intolerance

Release 7 — day 21, dose 1

2021-04-16

Symptoms: Emotional regulation

Release 8 — days 1–6 daily, dose 2

2021-04-27

Systemic reaction (other): Cognitive issues - problems with sensory overload; heat intolerance

2021-04-28

Systemic reaction (other): Heat intolerance

Release 8 — day 7, dose 2

2021-04-29

Systemic reaction (other): Heat intolerance

Release 9 — 3 months, dose 2

2021-07-22

Symptoms: - Terrible menstrual pain foe the last three cycles - A cold that will not go away (3 weeks in the running)- Elevated allergies (skin rash)

Release 10 — day 42, dose 3

2021-12-03

Symptoms: Lethargy

Release 11 — 3 months, dose 3

2022-01-21

Symptoms: Increased food sensitivities

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDysmenorrhoea · · ✓
SDEmotional disorder ✓ ✓ ✓
SDFood intolerance · · ✓
SDHypersensitivity · · ✓
SDLethargy · · ✓
SDNasopharyngitis · · ✓
SDPre-existing disease · · ✓
SDRash · · ✓
SDTemperature intolerance ✓ ✓ ✓
SROCognitive disorder ✓ ✓ ✓
SROInjection site bruising ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROSensory overload ✓ ✓ ✓
SROTemperature intolerance ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release